Resideo exec to sell 36,169 shares, $722K trade

Officer Robert Aarnes filed a Rule 144 notice to sell 36,169 REZI shares via option exercise after several large August–September 2026 sales.

Rhea-AI Filing Summary

Resideo Technologies, Inc. (REZI) has a notice under Rule 144 from officer Robert Aarnes for the proposed sale of 36,169 shares of common stock. The shares are tied to a stock option exercise for cash on September 4, 2026, with Morgan Stanley Smith Barney LLC as broker. Aarnes also reports prior open-market sales of 35,000 shares on September 2, 2026, and additional blocks of 40,000, 30,000, and 47,000 shares sold in August 2026.

Key Figures

Shares planned for sale under Rule 144: 36,169 shares Planned sale market value: $721,850.05 Resideo shares outstanding: 151,847,378 shares +5 more

8 metrics

Shares planned for sale under Rule 144 36,169 shares Proposed sale of Resideo Technologies common stock by officer Robert Aarnes

Planned sale market value $721,850.05 Associated with 36,169 Resideo Technologies shares proposed for sale

Resideo shares outstanding 151,847,378 shares Common stock outstanding context in the securities information section

Shares sold on September 2, 2026 35,000 shares Reported past 3 months sale by Robert Aarnes

Proceeds on September 2, 2026 sale $678,230.00 Sale of 35,000 Resideo shares

Shares sold on August 25, 2026 40,000 shares Reported past 3 months sale by Robert Aarnes

Proceeds on August 25, 2026 sale $775,772.00 Sale of 40,000 Resideo shares

Shares sold on August 17, 2026 47,000 shares Reported past 3 months sale by Robert Aarnes

Key Terms

Rule 144, Stock Option Exercise, Person for Whose Account the Securities are To Be Sold

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Common | 09/04/2026 | Stock Option Exercise | Issuer |"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Person for Whose Account the Securities are To Be Sold regulatory

"Name of Person for Whose Account the Securities are To Be Sold"

FAQ

What does the Form 144 filing disclose for RESIDEO TECHNOLOGIES, INC. (REZI)?

It discloses that officer Robert Aarnes intends to sell 36,169 shares of Resideo Technologies common stock under Rule 144, in connection with a stock option exercise for cash on September 4, 2026, using Morgan Stanley Smith Barney LLC as broker.

How many REZI shares does Robert Aarnes plan to sell in this Form 144?

Robert Aarnes plans to sell 36,169 shares of Resideo Technologies common stock. The planned sale is associated with a stock option exercise for cash dated September 4, 2026.

What is the stated market value of the REZI shares planned for sale?

The filing lists a market value of $721,850.05 for the 36,169 shares of Resideo Technologies common stock that are proposed to be sold under Rule 144.

What prior REZI stock sales by Robert Aarnes are reported in the past 3 months?

The notice reports sales of 35,000 shares on September 2, 2026; 40,000 shares on August 25, 2026; 30,000 shares on August 21, 2026; and 47,000 shares on August 17, 2026.

What proceeds are reported from recent REZI share sales by Robert Aarnes?

Reported proceeds include $678,230.00 for 35,000 shares on September 2, 2026; $775,772.00 for 40,000 shares on August 25, 2026; $605,070.00 for 30,000 shares on August 21, 2026; and $999,741.70 for 47,000 shares on August 17, 2026.

How will the planned REZI share sale by Robert Aarnes be executed?

The planned sale of 36,169 shares will be tied to a stock option exercise for cash on September 4, 2026, with Morgan Stanley Smith Barney LLC Executive Financial Services listed as the broker.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 04:03 PM Accepted by SEC EDGAR 09/04/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001754267
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RESIDEO TECHNOLOGIES, INC.
SEC File Number	001-38635
Address of Issuer	16100 N. 71st Street, Suite 450, Scottsdale ARIZONA 85254
Phone	(480) 573-5340
Name of Person for Whose Account the Securities are To Be Sold	ROBERT AARNES
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	36169	721850.05	151847378	09/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/04/2026	Stock Option Exercise	Issuer			36169	09/04/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROBERT AARNES 16100 N. 71st Street, Suite 450, Scottsdale AZ 85254	Common	09/02/2026	35000	678230.00
ROBERT AARNES 16100 N. 71st Street, Suite 450, Scottsdale AZ 85254	Common	08/25/2026	40000	775772.00
ROBERT AARNES 16100 N. 71st Street, Suite 450, Scottsdale AZ 85254	Common	08/21/2026	30000	605070.00
ROBERT AARNES 16100 N. 71st Street, Suite 450, Scottsdale AZ 85254	Common	08/17/2026	47000	999741.70

144: Remarks and Signature

Remarks
Date of Notice	09/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert B Aarnes
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)